Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA accepts for review Labopharm's trazodone NDA for major depressive disorder

Nov. 27, 2008

Sangamo's new zinc finger protein transcription factor neuroprotective in spinal injury model

Nov. 27, 2008

Antiallodynic activity of Adolor's novel potent NGF-TrkA antagonist

Nov. 26, 2008

UWA-0121 extends L-DOPA activity in primate model of Parkinson's disease

Nov. 26, 2008

MK-677 does not meet efficacy endpoints in a phase II Alzheimer's disease study

Nov. 26, 2008

DepoMed enters into exclusive license agreement with Solvay for DM-1796

Nov. 26, 2008

ChemDiv and Avineuro extend collaboration in Alzheimer's disease

Nov. 26, 2008

Neuromed completes enrollment for phase III trial of NMED-1077 in chronic low back pain

Nov. 26, 2008

Hemispherx enters major contract with Lovelace Respiratory Research Institute

Nov. 26, 2008

Xenazine tablets available in U.S. for chorea associated with HD

Nov. 25, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...